⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17100547 | 0.79 | — | — | |
| SCHEMBL6606020 | 0.69 | — | — | |
| SCHEMBL2264879 | 0.69 | — | — | |
| SCHEMBL10788422 | 0.69 | — | — | |
| SCHEMBL8633356 | 0.69 | — | — | |
| SCHEMBL439812 | 0.67 | — | — | |
| SCHEMBL11054393 | 0.67 | — | — | |
| SCHEMBL6466831 | 0.67 | — | — | |
| SCHEMBL4809247 | 0.67 | — | — | |
| SCHEMBL10944752 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3119799-A1 | ANTIMICROBIAL COMPOUNDS | Biomérieux (FR) | 2017-01-25 | — | — | EP | claimed |
| WO-2015140481-A1 | ANTIMICROBIAL COMPOUNDS | bioMérieux (FR) | 2015-09-24 | — | — | WO | claimed |
| EP-3119799-A1 | ANTIMICROBIAL COMPOUNDS | Biomérieux (FR) | 2017-01-25 | — | — | EP | disclosed |
| WO-2015140481-A1 | ANTIMICROBIAL COMPOUNDS | bioMérieux (FR) | 2015-09-24 | — | — | WO | disclosed |
| US-4783443-A | Amino acyl cephalosporin derivatives | THE UNIVERSITY OF CHICAGO (US) | 1988-11-08 | — | — | US | disclosed |
| WO-1987005297-A1 | CEPHALOSPORIN DERIVATIVES | THE UNIVERSITY OF CHICAGO (US) | 1987-09-11 | — | — | WO | disclosed |
| EP-0132441-A1 | ANTIBACTERIAL PEPTIDES | UNIVERSITY PATENTS, INC. (US) | 1985-02-06 | — | — | EP | disclosed |
| WO-1984002905-A1 | ANTIBACTERIAL PEPTIDES | UNIVERSITY PATENTS INC (US) | 1984-08-02 | — | — | WO | disclosed |